⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24738 | 0.72 | — | — | |
| SCHEMBL44936 | 0.58 | — | — | |
| SCHEMBL126616 | 0.55 | — | — | |
| SCHEMBL210137 | 0.55 | — | — | |
| SCHEMBL343352 | 0.50 | — | — | |
| 1,1-Dichloroethene SCHEMBL7620 | 0.50 | — | — | |
| SCHEMBL1908494 | 0.50 | — | — | |
| SCHEMBL1039815 | 0.50 | — | — | |
| SCHEMBL7072333 | 0.50 | — | — | |
| SCHEMBL6567632 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220184191-A1 | Nucleic acid vaccination using neo-epitope encoding constructs | EVAXION BIOTECH A/S (DK) | 2022-06-16 | — | — | US | claimed |
| EP-3937973-A1 | NUCLEIC ACID VACCINATION USING NEO-EPITOPE ENCODING CONSTRUCTS | Evaxion Biotech A/S (DK) | 2022-01-19 | — | — | EP | claimed |
| WO-2020182901-A1 | NUCLEIC ACID VACCINATION USING NEO-EPITOPE ENCODING CONSTRUCTS | EVAXION BIOTECH APS (DK) | 2020-09-17 | — | — | WO | claimed |
| US-20240173391-A1 | THERAPEUTIC COMBINATION FOR TREATING CANCER | Nykode Therapeutics ASA (NO) | 2024-05-30 | — | — | US | disclosed |
| WO-2024100196-A1 | CO-EXPRESSION OF CONSTRUCTS AND POLYPEPTIDES | Nykode Therapeutics ASA (NO) | 2024-05-16 | — | — | WO | disclosed |
| WO-2024092025-A1 | CONSTRUCTS AND THEIR USE | Nykode Therapeutics ASA (NO) | 2024-05-02 | — | — | WO | disclosed |
| EP-4337247-A1 | TOLERANCE-INDUCING CONSTRUCTS AND COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF IMMUNE DISORDERS | Nykode Therapeutics ASA (NO) | 2024-03-20 | — | — | EP | disclosed |
| EP-4337249-A2 | CO-EXPRESSION OF CONSTRUCTS AND IMMUNOINHIBITORY COMPOUNDS | Nykode Therapeutics ASA (NO) | 2024-03-20 | — | — | EP | disclosed |
| EP-4337251-A1 | TOLERANCE-INDUCING CONSTRUCTS AND COMPOSITION AND THEIR USE FOR THE TREATMENT OF IMMUNE DISORDERS | Nykode Therapeutics ASA (NO) | 2024-03-20 | — | — | EP | disclosed |
| EP-4337248-A2 | CO-EXPRESSION OF CONSTRUCTS AND IMMUNOSTIMULATORY COMPOUNDS | Nykode Therapeutics ASA (NO) | 2024-03-20 | — | — | EP | disclosed |
| EP-4333881-A1 | IMMUNOGENIC CONSTRUCTS AND VACCINES FOR USE IN THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS DISEASES | Nykode Therapeutics ASA (NO) | 2024-03-13 | — | — | EP | disclosed |
| WO-2022238395-A1 | TOLERANCE-INDUCING CONSTRUCTS AND COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF IMMUNE DISORDERS | Nykode Therapeutics ASA (NO) | 2022-11-17 | — | — | WO | disclosed |
| WO-2022233851-A1 | IMMUNOGENIC CONSTRUCTS AND VACCINES FOR USE IN THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS DISEASES | Nykode Therapeutics ASA (NO) | 2022-11-10 | — | — | WO | disclosed |
| US-20220184191-A1 | Nucleic acid vaccination using neo-epitope encoding constructs | EVAXION BIOTECH A/S (DK) | 2022-06-16 | — | — | US | disclosed |
| US-11307496-B2 | Metal brush layer for EUV patterning | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2022-04-19 | — | — | US | disclosed |
| WO-2022013277-A1 | APC TARGETING UNITS FOR IMMUNOTHERAPY | EVAXION BIOTECH A/S (DK) | 2022-01-20 | — | — | WO | disclosed |
| EP-3937973-A1 | NUCLEIC ACID VACCINATION USING NEO-EPITOPE ENCODING CONSTRUCTS | Evaxion Biotech A/S (DK) | 2022-01-19 | — | — | EP | disclosed |
| US-20210149298-A1 | METAL BRUSH LAYER FOR EUV PATTERNING | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2021-05-20 | — | — | US | disclosed |
| WO-2020182901-A1 | NUCLEIC ACID VACCINATION USING NEO-EPITOPE ENCODING CONSTRUCTS | EVAXION BIOTECH APS (DK) | 2020-09-17 | — | — | WO | disclosed |
| US-7439023-B2 | Method of isolating a nucleic acid using a material containing an amino group and a carboxyl group and positively charged at a first pH and a solid material for nucleic acid isolation used for the method | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-10-21 | — | — | US | disclosed |